Discovery of pyrrolopyridazines as novel DGAT1 inhibitors

被引：27

作者：

Fox, Brian M. ^{[1
]}

Iio, Kiyosei ^{[2
]}

Li, Kexue ^{[1
]}

Choi, Rebeka ^{[1
]}

Inaba, Takashi ^{[2
]}

Jackson, Simon ^{[1
]}

Sagawa, Shoichi ^{[2
]}

Shan, Bei ^{[1
]}

Tanaka, Masahiro ^{[2
]}

Yoshida, Atsuhito ^{[2
]}

Kayser, Frank ^{[1
]}

机构：

[1] Amgen Inc, Amgen S San Francisco, San Francisco, CA 94080 USA

[2] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Osaka 5691125, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 20期

关键词：

DGAT1; inhibitors; Pyrrolopyridazines; Acyl CoA: diacylglycerol acyltransferase; COA-DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; OBESITY; CLONING; RESISTANCE; INSULIN; FAMILY; TARGET;

D O I：

10.1016/j.bmcl.2010.08.066

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

new structural class of DGAT1 inhibitors was discovered and the structure-activity relationship was explored. The pyrrolotriazine core of the original lead molecule was changed to a pyrrolopyridazine core providing an increase in potency. Further exploration resulted in optimization of the propyl group at C7 and the discovery that the ester at C6 could be replaced by five-membered heterocyclic rings. The analogs prepared have DGAT1 IC(50) values ranging from >10 mu M to 48 nM. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6030 / 6033

页数：4

共 50 条

[21] Castor diacylglycerol acyltransferase type 1 (DGAT1) displays greater activity with diricinolein than Arabidopsis DGAT1
McKeon, Thomas A.
He, Xiaohua
BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2015, 4 (02) : 276 - 278
[22] Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation
Koul, Summon
Kurhade, Suresh
Bhosale, Sandeep
Naik, Keshav
Salunkhe, Videsh
Ravula, Sudhir
Punde, Prasad
Velayutham, Ravikumar
Tiwari, Atul
Ahl, Daniela
Malkapuram, Srividya
Mudagala, Vamsi
Raje, Amol
Umrani, Dhananjay
Tambe, Suhas
Patil, Poonam
Singh, Umesh
Bhuniya, Debnath
Hariharan, Narayanan
Mookhtiar, Kasim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 62
[23] Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors
Hynes, John, Jr.
Wu, Hong
Kempson, James
Duan, James J. -W.
Lu, Zhonghui
Jiang, Bin
Stachura, Sylwia
Tokarski, John S.
Sack, John S.
Khan, Javed A.
Lippy, Jonathan S.
Zhang, Rosemary F.
Pitt, Sidney
Shen, Guoxiang
Gillooly, Kate
McIntyre, Kim
Carter, Percy H.
Barrish, Joel C.
Nadler, Steven G.
Salter-Cid, Luisa M.
Fura, Aberra
Schieven, Gary L.
Pitts, William J.
Wrobleski, Stephen T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (14) : 3101 - 3106
[24] Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides
Serrano-Wu, Michael H.
Coppola, Gary M.
Gong, Yongjin
Neubert, Alan D.
Chatelain, Ricardo
Clairmont, Kevin B.
Commerford, Renee
Cosker, Theresa
Daniels, Thomas
Hou, Ying
Jain, Monish
Juedes, Marlene
Li, Lisha
Mullarkey, Tara
Rocheford, Erik
Sung, Moo Je
Tyler, Andrew
Yang, Qing
Yoon, Taeyoung
Hubbard, Brian K.
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (05): : 411 - 415
[25] Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability
Bali, Ustav
Barba, Oscar
Dawson, Graham
Gattrell, William T.
Horswill, James G.
Pan, David A.
Procter, Martin J.
Rasamison, Chrystelle M.
Smith, Colin P. Sambrook
Taylor-Warne, Amanda
Wong-Kai-In, Philippe
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 824 - 828
[26] Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1) FUNCTIONAL IMPORTANCE OF DGAT1 IN THE INTESTINAL FAT ABSORPTION
Cheng, Dong
Iqbal, Jahangir
Devenny, James
Chu, Ching-Hsuen
Chen, Luping
Dong, Jessica
Seethala, Ramakrishna
Keim, William J.
Azzara, Anthony V.
Lawrence, R. Michael
Pelleymounter, Mary Ann
Hussain, M. Mahmood
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (44) : 29802 - 29811
[27] A look into DGAT1 through the EM lenses
Panigrahi, Rashmi
Glover, J. N. Mark
Nallusamy, Saranya
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2023, 1865 (01):
[28] DGAT1 is required for vitamin A homeostasis in the skin
Shih, M. Y.
Yen, C. L.
Zhou, P.
Farese, R. V.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S104 - S104
[29] Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety
He, Shuwen
Lai, Zhong
Hong, Qingmei
Shang, Jackie
Reibarkh, Mikhail
Kuethe, Jeffrey T.
Liu, Jian
Guiadeen, Deodial
Krikorian, Arto D.
Cernak, Timothy A.
Dykstra, Kevin D.
Sperbeck, Donald M.
Wu, Zhicai
Yu, Yang
Yang, Ginger X.
Jian, Tianying
Verras, Andreas
Sonatore, Lisa M.
Wiltsie, Judyann
Chung, Christine C.
Murphy, Beth A.
Gorski, Judith N.
Liu, Jinqi
Xiao, Jianying
Wolff, Michael
Tong, Sharon X.
Madeira, Maria
Karanam, Bindhu, V
Shen, Dong-Ming
Balkovec, James M.
Pinto, Shirly
Nargund, Ravi P.
DeVita, Robert J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (10) : 1182 - 1186
[30] Identification and characterization of a novel DGAT1 missense mutation associated with congenital diarrhea
Gluchowski, Nina L.
Chitraju, Chandramohan
Picoraro, Joseph A.
Mejhert, Niklas
Pinto, Shirly
Xin, Winnie
Kamin, Daniel S.
Winter, Harland S.
Chung, Wendy K.
Walther, Tobias C.
Farese, Robert V., Jr.
JOURNAL OF LIPID RESEARCH, 2017, 58 (06) : 1230 - 1237

← 1 2 3 4 5 →